DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?


OverviewForecastFinancialsChartTranscripts

DiaMedica Therapeutics Ownership Summary


DiaMedica Therapeutics is owned by 18.99% institutional investors, 27.74% insiders, and 53.28% retail investors. Cooperman leon g is the largest institutional shareholder, holding 4.30% of DMAC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.74% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDiaMedica Therapeutics18.99%27.74%53.28%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cooperman leon g2.02M4.30%$13.68M
Blackrock funding, inc. /de1.86M3.95%$12.57M
Millennium management935.59K1.99%$6.33M
Paragon associates & paragon associates ii joint venture875.00K1.86%$5.92M
Geode capital management780.52K1.66%$5.29M
Vanguard group723.12K1.46%$5.76M
State street644.21K1.37%$4.36M
First manhattan co. llc.455.00K0.97%$3.08M
Bleichroeder lp382.32K0.81%$2.59M
Northern trust338.53K0.72%$2.29M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paragon associates & paragon associates ii joint venture875.00K8.05%$5.92M
Cooperman leon g2.02M0.45%$13.68M
Bleichroeder lp382.32K0.45%$2.59M
Members wealth101.38K0.39%$655.94K
Corient ia60.00K0.38%$406.20K
Magnolia capital advisors77.41K0.10%$524.03K
Eam investors91.42K0.07%$618.95K
Private capital management50.00K0.03%$338.50K
Catalyst financial partners38.46K0.03%$260.35K
Awm investment company36.00K0.03%$243.72K

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust187.72K0.00%187.72K
Millennium management935.59K0.00%167.03K
Ci private wealth140.00K0.00%140.00K
Cantor fitzgerald, l. p.100.00K0.01%100.00K
Advisor group319.68K0.00%72.70K

Top Sellers

HolderShares% AssetsChange
Morgan stanley105.42K--442.19K
Aristides capital---106.33K
Wellington management group llp---103.70K
Fred alger management---83.14K
683 capital management---76.12K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust187.72K0.00%187.72K$1.27M
Ci private wealth140.00K0.00%140.00K$961.80K
Cantor fitzgerald, l. p.100.00K0.01%100.00K$687.00K
Exoduspoint capital management, lp60.01K0.00%60.01K$406.27K
Renaissance52.52K0.00%52.52K$355.58K

Sold Out

HolderChange
Srs capital advisors-32.00
Federation des caisses desjardins du quebec-230.00
Tortoise investment management-500.00
Point72 (difc)-642.00
Legend financial advisors-1.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202679-16.84%8,920,167-26.00%183.22%37-32.73%18-10.00%
Dec 31, 202522-72.50%1,075,644-91.57%20.25%11-80.00%5-54.55%
Sep 30, 202519-65.45%1,067,231-87.45%20.63%10-73.68%4-
Jun 30, 202557-5.00%8,620,53214.72%206.52%3911.43%5-50.00%
Mar 31, 20256027.66%7,514,09211.67%177.08%3525.00%10100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF747.20K1.74%-
Vanguard Total Stock Mkt Idx Inv839.16K1.63%-18.51K
iShares Russell 2000 ETF798.38K1.48%6.72K
Vanguard Institutional Extnd Mkt Idx Tr356.76K0.66%23.31K
Fidelity Small Cap Index331.53K0.62%1.60K
iShares Russell 2000 Growth ETF279.93K0.52%722.00
Russell 2000 Equity Index Fund B207.05K0.38%31.00
State St Russell Sm/Mid Cp® Indx SL Cl I204.30K0.38%-
Vanguard Russell 2000 ETF173.12K0.32%3.57K
Fidelity Extended Market Index165.33K0.31%3.07K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 21, 2025STAHLBERG JAN-Buy$1.55M
Nov 20, 2025STAHLBERG JAN-Buy$951.21K
Nov 25, 2025STAHLBERG JAN-Buy$626.82K
Nov 24, 2025STAHLBERG JAN-Buy$317.72K
Nov 19, 2025STAHLBERG JAN-Buy$1.73M

Insider Transactions Trends


DateBuySell
2025 Q33-
2025 Q2--
2025 Q1--
2024 Q22-
2024 Q1--

DMAC Ownership FAQ


Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 18.99%, followed by 27.74% insiders and 53.27% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 35.75%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (2.02M shares, 4.30%), Blackrock funding, inc. /de (1.86M shares, 3.95%), and Millennium management (935.59K shares, 1.99%). Together, they hold 10.24% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

BlackRock is not among the top 10 institutional shareholders of DiaMedica Therapeutics.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.05% of its assets in 875K DiaMedica Therapeutics shares, valued at 5.92M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of DiaMedica Therapeutics shares, with 1.74% of its total shares outstanding invested in 747.2K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools